BBB

Celgene Corporation 5.0% 15-AUG-2045

No trades
See on Supercharts
Overview
Analysis

Key terms


Outstanding amount
‪15.71 M‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
5.00% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
6.87%
Maturity date
Aug 15, 2045
Term to maturity
20 years

About Celgene Corporation 5.0% 15-AUG-2045


Issuer
Celgene Corp.
Sector
Health Technology
Industry
Biotechnology
Home page
Issue date
Aug 12, 2015
FIGI
BBG009QXNJL9
Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

See how Celgene Corp. is moving with its highest-yielding bonds.